Results 21 to 30 of about 55,278 (277)
Background There is paucity of data on quality of life as a dimension of treatment outcome among Visceral Leishmaniasis and HIV coinfected patients. This study sought to explore perceived quality of life among Visceral Leishmaniasis and HIV coinfected ...
Mekuriaw Alemayehu +3 more
doaj +1 more source
ANÁLISE DOS FATORES QUE INFLUENCIAM A OCORRÊNCIA DA LEISHMANIOSE VISCERAL HUMANA
Objective: to analyze the factors that influence the occurrence of Human Visceral Leishmaniasis in the state of Paraíba, Brazil. Methods: ecological study, developed with data from 2012 to 2017, collected in a reference laboratory in the state and in the
Allan Batista Silva +5 more
doaj +1 more source
Diagnosis of visceral leishmaniasis [PDF]
Leishmaniasis is a vector-borne disease with up to 350 million people at risk of infection worldwide. Among its different clinical manifestations, visceral is the most severe form. Since clinical features of visceral leishmaniasis (VL) mimic several other common diseases, accurate diagnosis is crucial as the treatment is associated with significant ...
Shyam Sundar +3 more
openaire +3 more sources
Presentation of AIDS with Disseminated Cutaneous and Visceral Leishmaniasis in Iran
Leishmaniasis is an infectious disease in form of visceral (VL), cutaneous (CL), and mucocutaneous (MCL) leishmaniasis. Immunocompromised patients have increased risk of Leishmania infection, especially in endemic areas for visceral leishmaniasis, where
Mohammadali Davarpanah +2 more
doaj +1 more source
Low castes have poor access to visceral leishmaniasis treatment in Bihar, India [PDF]
Objectives Bihar, the poorest state in India, concentrates most of the visceral leishmaniasis (VL) cases in the country. A large proportion of the poor rural communities where VL is endemic are marginalized by their socio-economic status, intrinsically ...
Alvar +22 more
core +2 more sources
A case of visceral leishmaniasis imported from Armenia
The relevance of the problem of visceral leishmaniasis is due to the severity of clinical manifestations, as well as the need for immediate etiotropic therapy.
A. L. Rossina +7 more
doaj +1 more source
Treatment of visceral leishmaniasis [PDF]
Growing antimony resistance in patients with visceral leishmaniasis (VL) over last two decades, especially in Indian subcontinent, renders this cheap and easily available drug useless for a vast majority of patients. Use of the second line drug pentamidine isethionate, a toxic drug with declining efficacy, has largely been abandoned.
openaire +4 more sources
Human visceral leishmaniasis and relationship with vector and canine control measures
OBJECTIVE Estimate the coverage of control measures of visceral leishmaniasis and relate them with the occurrence of human visceral leishmaniasis in endemic urban area.
Danielle Nunes Carneiro Castro Costa +9 more
doaj +1 more source
Epidemiology of visceral leishmaniasis [PDF]
Leishmania species are the causative agents of leishmaniasis, a neglected tropical disease. These parasitic protozoans are usually transmitted between vertebrate hosts by the bite of blood sucking female phlebotomine sand flies. This review focuses on the two parasites causing most human visceral leishmaniasis (VL), which leads to substantial health ...
openaire +5 more sources
The recombinant cysteine proteinase B (CPB) from Leishmania braziliensis and its domains: promising antigens for serodiagnosis of cutaneous and visceral leishmaniasis in dogs. [PDF]
Leishmaniasis represents a group of parasitic diseases caused by a protozoan of the genus Leishmania and is widely distributed in tropical and subtropical regions.
Basombrío, Manuel Alberto +10 more
core +1 more source

